TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

BACKGROUND: About 20% of resectable oesophageal carcinoma is resistant to preoperative chemoradiotherapy. Here we hypothesised that the expression of the antiapoptotic gene Baculoviral inhibitor of apoptosis repeat containing (BIRC)3 induced by the transforming growth factor β activated kinase 1 (TA...

Descripción completa

Detalles Bibliográficos
Autores principales: Piro, G, Giacopuzzi, S, Bencivenga, M, Carbone, C, Verlato, G, Frizziero, M, Zanotto, M, Mina, M M, Merz, V, Santoro, R, Zanoni, A, De Manzoni, G, Tortora, G, Melisi, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578082/
https://www.ncbi.nlm.nih.gov/pubmed/26291056
http://dx.doi.org/10.1038/bjc.2015.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578082/
https://www.ncbi.nlm.nih.gov/pubmed/26291056
http://dx.doi.org/10.1038/bjc.2015.283

Ejemplares similares